A New Audio Interview with Pat Gosselin, President of PureSnax, is now at SmallCapVoice.com

AUSTIN, Texas, April 12, 2016 -- SmallCapVoice.com, Inc. (SCV) and PureSnax International, Inc. (OTC PINK:PSNX) ("PureSnax" or "Company"), an innovative functional food and healthy snacks company, announced today that a new audio interview with the Company is now available. The interview can be heard at http://smallcapvoice.com/blog/4-11-16-smallcapvoice-interview-with-puresnax-international-inc-psnx/

Pat Gosselin, President of PureSnax, called in to SmallCapVoice.com to provide the listening audience with a comprehensive overview of the Company’s history, unique business model as well as his own candid insights into the goals for the Company in 2016 and beyond.

"Our Company has come a long way in a short amount of time and we know that our investors want to hear from us about our future plans," stated Gosselin. "We appreciate the opportunity to share our story with our shareholders and the SmallCapVoice.com listening audience."

About SmallCapVoice.com

SmallCapVoice.com is a recognized corporate investor relations firm, with clients nationwide, known for its ability to help emerging growth companies build a following among retail and institutional investors. SmallCapVoice.com utilizes its stock newsletter to feature its daily stock picks, audio interviews, as well as its clients' financial news releases. SmallCapVoice.com also offers individual investors all the tools they need to make informed decisions about the stocks they are interested in. Tools like stock charts, stock alerts, and Company Information Sheets can assist with investing in stocks that are traded on the OTC BB and Pink Sheets. To learn more about SmallCapVoice.com and their services, please visit http://www.smallcapvoice.com/services.html.

About PureSnax International, Inc. (PSNX)

PureSnax International, Inc. is a functional food and healthy snacks company engaged in development, sourcing, branding and distribution of healthy food and snack products through its wellness brand.

Disclaimer: Notice Regarding Forward-Looking Statements

This press release contains "forward-looking statements," as that term is defined in the United States Securities Act of 1933 and Securities Exchange Act of 1934. Statements in this press release, which are not purely historical, are forward-looking statements and include any statements regarding beliefs, plans, expectations, or intentions regarding the future. Actual results could differ from those projected in any forward-looking statements due to numerous factors, including, among others, the inherent uncertainties associated with intellectual property protection, marketing and sale, manufacturing and distribution, and difficulties associated with obtaining financing. Investors should also refer to the risk factors disclosure outlined in our most recent annual report for our last fiscal year, our quarterly reports, and other periodic reports filed from time-to-time with the Securities and Exchange Commission. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements. Although we believe the beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that such beliefs, plans, expectations, or intentions will prove to be accurate.

Health Related Information 

The information and contents contained in the following PureSnax International Inc. interview is provided for informational purposes only and is not meant to substitute for the advice provided by your doctor or other health care professional. You should not use the information available on or through the PureSnax International Inc. Interview for diagnosing or treating a health problem or disease, or prescribing any medication. Information and statements regarding dietary and other health care supplements have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease. You should read carefully all product packaging prior to use and consult with your health care professionals.  

Contact:
Investor/Media 

PureSnax International, Inc. (PSNX) 
Investor Relations
(888) 682-6999 (Toll-free)
E-mail: [email protected] 
Website: www.puresnax.com

For SmallCapVoice.com 
Stuart T. Smith 
512-267-2430 
[email protected]